迄今为止,原发性肝癌(以下简称肝癌)的治疗仍以手术切除效果最佳,但由于其起病隐匿、多中心发生、易复发等特点,临床发现时多属中晚期,能手术切除者仅为10%左右[1]。对不能切除的肝癌,近年来采用超声或CT引导下多种药物瘤体内注射,由于其具有操作简单,不良反应少、损伤小及疗效 So far, the treatment of primary liver cancer (hereinafter referred to as liver cancer) is still the best surgical resection, but because of its occult onset, polycentric, easy to relapse, etc., clinical findings are mostly advanced, resectable Only about 10% [1]. For unresectable liver cancer, in recent years, ultrasound or CT-guided injection of various drugs in vivo, due to its simple operation, less adverse reactions, less damage and efficacy